Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Long-term Buy Signal

<< Previous

Bullboard Posts

Next >>

Post by consultant99on Aug 20, 2022 12:57am

578 Views

Post# 34908941

Long-term Buy Signal

TD Waterhouse's technical service signaled a long term buy signal based on a diamond continuation chart pattern with a projected price range of 0.68 to 0.76 per share.

This projection fits nicely with the fundamentals of a new data release on the phase 2 trial and the anticipation of the results from the Covid vaccine animal testing.

The price forecast is the next step in what we all hope will be a long climb higher for Theralase's share price.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in